1. Abstract
The Type D Personality Scale (DS14) is a brief, widely validated psychometric instrument developed by Johan Denollet to assess the distressed (Type D) personality construct. Type D personality is characterized by the joint presence of two stable personality traits: Negative Affectivity (NA), defined as the tendency to experience negative emotions across time and situations, and Social Inhibition (SI), defined as the tendency to suppress the expression of emotions and behavior in social interactions to avoid disapproval or rejection. The DS14 consists of 14 self-report items divided equally into two 7-item subscales evaluated on a 5-point Likert scale ranging from 0 (False) to 4 (True). Two items on the Social Inhibition subscale are reverse-scored. A categorical classification of Type D personality is determined using a predefined cutoff score of 10 or higher on both the NA and SI subscales (NA ≥ 10 and SI ≥ 10), though continuous dimensional analyses utilizing multiplicative interaction terms (NA × SI) are also routinely recommended in behavioral medicine research.
Extensive psychometric investigations across diverse clinical cohorts—including patients with coronary artery disease, heart failure, peripheral arterial disease, and hypertension—as well as healthy general populations, confirm that the DS14 demonstrates strong internal consistency (Cronbach’s α typically between .86 and .89 for NA, and .82 and .88 for SI) and robust test-retest reliability across intervals ranging from one month to several years. Construct validity is supported by confirmatory factor analyses establishing a stable two-factor orthogonal or modestly correlated structure that is cross-culturally invariant. Criterion and predictive validity analyses link high DS14 scores to an elevated risk of adverse cardiovascular outcomes, major adverse cardiac events (MACE), cardiovascular mortality, poor treatment adherence, impaired health-related quality of life, and dysregulated neuroendocrine and immune mechanisms, including elevated inflammatory cytokines (e.g., TNF-α, IL-6) and blunted cardiovascular reactivity.
2. Keywords
Type D personality, DS14, Negative Affectivity, Social Inhibition, psychometrics, cardiovascular disease, behavioral medicine, stress reactivity, health-related quality of life, factor analysis
3. Authors
The DS14 was developed and standardized by Johan Denollet, Ph.D., Emeritus Professor of Medical Psychology at the Department of Medical and Clinical Psychology, CoRPS (Center of Research on Psychological and Somatic Disorders), Tilburg University, Tilburg, The Netherlands. Professor Denollet pioneered the conceptualization of the distressed personality profile in the 1990s and subsequently standardized its assessment in 2005. Significant collaborative psychometric standardization across international contexts has included research contributions from Susanne S. Pedersen (Department of Psychology, University of Southern Denmark), Christoph Herrmann-Lingen (Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany), and Nina Kupper (Tilburg University, The Netherlands).
4. Purpose
The primary purpose of the Type D Personality Scale (DS14) is to identify individuals who exhibit a synergy of chronic emotional distress and interpersonal inhibition. Prior to the formal operationalization of Type D personality, medical psychology and behavioral cardiology heavily focused on the Type A coronary-prone behavior pattern, characterized by time urgency, competitive drive, and overt hostility. However, subsequent epidemiological investigations demonstrated inconsistent and conflicting predictive validity regarding hard clinical endpoints. Denollet addressed this gap by identifying a distinct, robust personality configuration that combines vulnerability to experiencing negative affect with a conscious or habitual restraint against externalizing such distress in interpersonal encounters.
In clinical practice, the DS14 serves as a rapid screening instrument designed to stratify cardiovascular risk, identify non-adherence tendencies, and detect patients at heightened vulnerability for post-infarction depression, anxiety disorders, and reduced adherence to cardiac rehabilitation regimens. From an epidemiological and behavioral cardiology perspective, the purpose of the DS14 is to quantify psychological distress not merely as transient psychiatric symptomatology (such as acute major depressive episodes or situational anxiety states), but as an enduring, traits-based taxonomy that systematically alters cardiovascular, autonomic, and immunologic homeostasis over time.
In research domains, the DS14 is employed to explore the pathophysiological pathways linking chronic psychological distress with somatic disease progression. Specifically, researchers utilize the scale to evaluate endothelial dysfunction, systemic inflammation, platelet activation, and heart rate variability (HRV). Because the DS14 is brief, self-administered, and easily scored, it is routinely integrated into large-scale clinical trials and longitudinal cohort studies worldwide to control for or directly measure the prognostic role of patient personality architecture.
5. Psychological Construct
The Type D construct is formulated as a two-dimensional personality taxonomy rooted in contemporary personality science, specifically drawing from the broad dimensions of Neuroticism and Extraversion found in the Five-Factor Model of personality. Rather than representing an acute psychopathological condition or a formal Axis I/II psychiatric disorder as classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM), Type D represents a stable, non-pathological typology reflecting standard individual differences that interact to create heightened psychosomatic vulnerability.
Negative Affectivity (NA)
Negative Affectivity refers to the general, stable disposition to experience negative emotions across varying situations and temporal frames. Individuals scoring high on the NA subscale are predisposed to feelings of dysphoria, worry, irritability, apprehension, and an overall gloomy or pessimistic outlook on life. When confronted with daily stressors or health crises, such as the diagnosis of an acute myocardial infarction, high-NA individuals experience heightened emotional reactivity and cognitive appraisals characterized by catastrophe, helplessness, and heightened perceived threat. Items such as “I often feel unhappy,” “I take a gloomy view of things,” and “I often find myself worrying about something” directly tap into this chronic emotional state.
Social Inhibition (SI)
Social Inhibition represents the conscious or habitual tendency to suppress the overt expression of emotions, ideas, and behaviors during interpersonal interactions. Individuals scoring high on SI report feeling awkward, tense, reticent, and insecure around others, primarily stemming from an anticipatory fear of social disapproval, negative appraisal, or rejection. Consequently, they maintain emotional and interpersonal distance, avoid initiating conversations, and feel socially alienated. Representative items include “I am a closed kind of person,” “I find it hard to start a conversation,” and “I would rather keep people at a distance.”
The Synergistic Interaction: Type D Typology
The core theoretical tenet of the Type D construct is that neither Negative Affectivity nor Social Inhibition operating independently confers the full magnitude of cardiovascular and psychological risk; rather, it is their co-occurrence that is pathogenic. An individual high in NA but low in SI experiences chronic negative emotions but actively seeks social support, vents emotions, and discusses physical symptoms with healthcare providers. Conversely, an individual high in SI but low in NA maintains social distance but remains emotionally unbothered and free of chronic affective distress. When high NA and high SI converge, the individual experiences high baseline levels of negative affect yet lacks the behavioral mechanisms, interpersonal security, or social capital required to express distress and solicit external support, leading to internal psychological strain and sustained physiological arousal.
6. Theoretical Framework
The theoretical framework underpinning the DS14 synthesizes biological psychology, health psychology, and structural trait theory. Structurally, the DS14 maps directly onto the overarching trait dimensions of Neuroticism (NA) and Introversion (SI), mirroring the structural models of personality proposed by Hans Eysenck and later expanded by Costa and McCrae. However, unlike general personality inventories such as the NEO-PI-R, the DS14 was specifically designed to capture the exact facets of these broad traits that operate as potent vulnerability factors for chronic somatic distress.
Psychophysiologically, the Type D framework is grounded in the inhibition-stress model, initially articulated by James Pennebaker and expanded in behavioral medicine. According to this model, actively inhibiting feelings, thoughts, and behaviors requires chronic, effortful physiological and neurological work. Suppressing emotional expression activates the sympathetic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis, leading to elevated basal cortisol levels, impaired cortisol awakening responses, and continuous autonomic arousal. When an individual continuously generates high levels of negative affect while simultaneously maintaining systemic behavioral inhibition, this sustained neuroendocrine activation promotes endothelial damage, enhances coronary plaque instability, promotes pro-inflammatory cytokine release (e.g., C-reactive protein, interleukin-6), and impairs parasympathetic modulation of the heart, indexed by diminished heart rate variability.
Behaviorally, the theoretical framework incorporates social-cognitive models of health behavior. Type D individuals typically harbor profound skepticism regarding healthcare interactions, avoid discussing worsening symptoms due to fear of embarrassment or appearing burdensome, demonstrate lower medication compliance, and participate less frequently in physical activity or cardiac rehabilitation programs, thereby accelerating clinical disease progression through multiple converging pathways.
7. Validity
The validity of the DS14 has been systematically established across diverse medical and non-medical samples across North America, Europe, and Asia.
Construct and Convergent Validity
Construct validity is substantiated by high correlations between the DS14 Negative Affectivity subscale and validated measures of psychological distress, such as the Hospital Anxiety and Depression Scale (HADS; correlations typically range from r = .60 to .75 with both HADS-Anxiety and HADS-Depression) and the Beck Depression Inventory (BDI-II). The Social Inhibition subscale correlates significantly with measures of social introversion, trait shyness, and the social withdrawal subscales of the Multidimensional Personality Questionnaire. Importantly, despite correlating with depressive symptoms, longitudinal studies demonstrate that the DS14 assesses a stable personality vulnerability that remains stable even when episodic depressive or anxious episodes remit.
Discriminant Validity
Discriminant validity is supported by the modest correlation between the NA and SI subscales themselves (typically r = .30 to .45), demonstrating that while they share some variance common to interpersonal distress, they represent distinct, non-redundant personality domains. Furthermore, factor analyses show that items from the DS14 do not cross-load significantly onto somatic symptom scales or physical health indices, verifying that the scale measures psychological traits rather than confounding somatic manifestations of underlying physical disease.
Predictive and Criterion Validity
Predictive validity is the cornerstone of the DS14’s clinical utility. In longitudinal studies of patients following percutaneous coronary intervention (PCI) or myocardial infarction (MI), individuals classified as Type D by the DS14 have consistently exhibited an elevated relative risk (typically hazard ratios ranging between 1.5 and 3.0) of all-cause mortality, cardiac mortality, and recurrent non-fatal myocardial infarction after adjusting for established biomedical risk factors such as left ventricular ejection fraction, age, and multi-vessel disease. Type D personality has also been reliably shown to predict poor patient-reported outcomes, including persistent health-related quality of life decrements measured via the SF-36 and MacNew Heart Disease Health-Related Quality of Life questionnaires.
8. Reliability
The psychometric reliability of the DS14 has been confirmed in both general community cohorts and specialized medical registries.
Internal Consistency
In the seminal standardization study conducted by Denollet (2005) involving 3,678 participants (both healthy individuals and coronary patients), internal consistency for both subscales was high. The Negative Affectivity subscale yielded a Cronbach’s alpha of α = .88 in cardiac patients and α = .86 in the general population. The Social Inhibition subscale demonstrated a Cronbach’s alpha of α = .86 in cardiac patients and α = .88 in the general population. Subsequent cross-cultural validations across German, Italian, Polish, Chinese, Korean, and Danish populations have replicated these findings, consistently reporting alpha coefficients exceeding .80 for both subscales.
Test-Retest Reliability
Because Type D is conceptualized as a chronic, stable personality structure, temporal stability is critical. Over a short-term interval of 1 month, test-retest reliability was r = .82 for Negative Affectivity and r = .82 for Social Inhibition. Long-term studies spanning 3-month, 1-year, and 5-year intervals confirm remarkable rank-order temporal stability (test-retest correlations ranging between r = .65 and r = .78), demonstrating that the DS14 measures personality traits that persist across fluctuating situational circumstances and acute medical treatments.
9. Factor Analysis
The internal structural validity of the DS14 has been extensively scrutinized using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).
Exploratory Factor Analysis (EFA)
In the initial instrument development studies, principal component analyses and exploratory factor analyses with both varimax and oblimin rotations confirmed a two-factor solution explaining over 50% of the total variance. All 7 items designated to Negative Affectivity loaded strongly on their primary factor (loadings ranging from .62 to .82) with negligible cross-loadings on the Social Inhibition factor (< .25). Similarly, all 7 Social Inhibition items loaded robustly on their designated factor (loadings ranging from .59 to .84), confirming strong structural independence.
Confirmatory Factor Analysis (CFA)
Confirmatory factor analyses in diverse international clinical cohorts have universally affirmed the superiority of a two-factor model over a unidimensional or higher-order single-factor structure. Typical model fit indices in structural equation modeling demonstrate robust statistical fit:
- Comparative Fit Index (CFI): ≥ .94 to .97
- Tucker-Lewis Index (TLI): ≥ .93 to .96
- Root Mean Square Error of Approximation (RMSEA): .045 to .065 (90% CI [.038, .068])
- Standardized Root Mean Square Residual (SRMR): ≤ .055
Multi-group CFA studies have established measurement invariance (configural, metric, and scalar invariance) across gender, age groups, and patient versus non-patient samples, verifying that the DS14 functions equivalently across sociodemographic and clinical groups.
10. Instrument / Measurement Tool
- Test Type: Standardized self-report psychometric personality scale.
- Administration Format: Paper-and-pencil or computerized self-administered questionnaire; completion time is approximately 3 to 5 minutes.
- Item Count: 14 items total, organized into two distinct 7-item subscales: Negative Affectivity (NA) and Social Inhibition (SI).
- Authentic Response Scale: 5-point Likert scale:
- 0 = False
- 1 = Rather false
- 2 = Neutral
- 3 = Rather true
- 4 = True
- Subscale Allocation:
- Negative Affectivity (NA): Items 2, 4, 5, 7, 9, 12, 13 (score range 0–28).
- Social Inhibition (SI): Items 1, 3, 6, 8, 10, 11, 14 (score range 0–28).
- Reverse Scoring Rules: Items 1 and 3 on the Social Inhibition subscale must be reverse-scored prior to calculating sums (0 = 4, 1 = 3, 2 = 2, 3 = 1, 4 = 0).
- Scoring and Categorization:
- Subscale scores are calculated by summing the respective item scores (each subscale ranges from 0 to 28).
- A respondent is classified as having a Type D personality if they achieve a score of 10 or greater on both subscales (NA ≥ 10 and SI ≥ 10).
- In research settings, researchers are also encouraged to treat NA and SI as continuous variables, entering the main effects and the continuous interaction term (NA × SI) into regression models.
11. Permissions & Fee and Test Year
The Type D Personality Scale (DS14) was published in 2005 by Dr. Johan Denollet. The scale is in the public domain for academic, scientific, non-commercial research, and individual clinical practice settings. No licensing fees, permissions, or royalty payments are required to administer the DS14 in standard research or non-profit clinical studies, provided appropriate academic citation is credited to the original author (Denollet, 2005). Commercial entities, proprietary pharmaceutical clinical trials, or commercial software developers intending to incorporate the scale into fee-for-service digital health platforms should contact Tilburg University or the author for formal licensing agreements.
12. References
Denollet, J. (2000). Type D personality: A potential risk factor for cardiac events. Current Cardiology Reports, 2(3), 212–218. https://doi.org/10.1007/s11886-000-0068-9
Denollet, J. (2005). DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosomatic Medicine, 67(1), 89–97. https://doi.org/10.1097/01.psy.0000149256.81953.49
Denollet, J., Sys, S. U., Stroobant, N., Rombouts, H., Gillebert, T. C., & Brutsaert, D. L. (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. The Lancet, 347(8999), 417–421. https://doi.org/10.1016/S0140-6736(96)90007-0
Kupper, N., & Denollet, J. (2018). Type D personality as a risk factor in coronary heart disease: a review of current evidence. Current Cardiology Reports, 20(11), 104. https://doi.org/10.1007/s11886-018-1049-9
Pedersen, S. S., & Denollet, J. (2006). Type D personality, cardiac events, and impaired quality of life: A review. European Journal of Cardiovascular Prevention & Rehabilitation, 13(6), 800–806. https://doi.org/10.1097/01.hjr.0000239466.86195.4f
Sumi, K. (2020). Reliability and validity of the Japanese version of the DS14 for measuring Type D personality. Psychological Reports, 123(2), 528–543. https://doi.org/10.1177/0033294118818585